Jobs
View more job listings or post a job
Boston Biomedical Inc SR/Clinical Research Scientist - Clinical Development - Oncology 
Applied Molecular Transport (AMT) Research Associate, Pharmacology/Biology
Applied Molecular Transport (AMT) Senior Scientist, Pharmacology/Biology
RAPT Therapeutics Research Associate, DMPK
Jazz Pharmaceuticals Senior Manager, Clinical Pharmacology
Nektar Therapeutics Research Associate III
Nektar Therapeutics Sr. Scientist, Bioanalytical
Genentech, Inc. Associate Scientist/Scientist, Drug Metabolism and Pharmacokinetics
Jubilant Discovery Services Senior Manager Business Development
Post a job

Workshop

Antibody Drug Conjugates: Chemistry, Biology, Pharmacokinetics and Toxicology


Speakers: Jagath Junutula (Cellerant), Andy Polson (Genentech) , Toni Kline (Sutro), Chetana Rao (BMS), Donglu Zhang (Genentech), Keyang Xu, PhD (Genentech), Melissa Schutten (Genentech)
Organizers: Thomas Pillow (Genentech)
Date: 2018-09-12
Time: 8:45-16:00 Pacific Time
Registration fee (USD): Regular: $195; For unemployed or students: $30; Academic: $125; For major-sponsor rep (incl lunch): $0; For vendor-show rep: $35
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (2)Applied BioMath, LLC; Intertek
Vendor show vendors registered to date: (24)AIT Bioscience; Alturas Analytics; Applied StemCell, Inc.; Averica Discovery Services; BioPharmEquip; Bruker; JOINN Labs; KCAS Bioanalytical & Biomarker Services; MabPlex; Medpace; MicroConstants; Pacific BioLabs; PHARMout Laboratories; Promega; Q2 Solutions; QPS; SCIEX; Sekisui XenoTech, LLC; Selvita Inc.; Sepax Technologies; Shimadzu Scientific Instruments, Inc; Sigma Aldrich; SRI International; WuXi AppTec
Registration: http://www.PBSS.org
Registration deadline:2018-09-11  (it will close sooner if the seating cap is reached)

About the Topic

Linking a small-molecule cytotoxic drug to a monoclonal antibody takes the strengths of both while potentially mitigating the liabilities. The resulting bioconjugates, known as antibody−drug conjugates or ADCs, have been validated clinically, with four approved anti-cancer agents for solid and hematological cancers. This workshop will broadly discuss the strategies for designing, constructing and analyzing ADCs utilizing the latest advances in the field.

This workshop will cover the following specific topics:

  • Overview of antibody-drug conjugates (ADCs) and clinical progress
  • Selecting a target for ADCs
  • The chemistry of linkers and drugs
  • Site-specific conjugation
  • Analytical characterization of ADCs
  • ADC bioanalysis & pharmacokinetics
  • Preclinical safety/toxicology

Workshop Agenda: 

Time Topic  Presenter
8:45-9:00 Welcome and Introduction Thomas Pillow
9:00-9:45 1. ADC Discovery & Development Jagath Junutula
9:45-10:30 2. ADCs for Hematological Malignancies Andy Polson
10:30-10:45 Break  
10:45-11:30 3. Conjugation Modalities for ADC Generation Chetana Rao
11:30-12:30 Lunch  
12:30-1:15 4. ADC Chemistry Toni Kline
1:15-2:00 5. Small Molecule DMPK for ADCs Donglu Zhang
2:00-2:15 Break  
2:15-3:00 6. Bioanalysis of ADCs   Keyang Xu
3:00-3:45 7. ADC Safety/Toxicity Melissa Schutten
3:45-4:15 Panel Discussion All
4:15-4:30 Final Remarks Thomas Pillow

 


2019-12-10, In Vitro Diagnostics (IVD) & Companion Diagnostics (CDx): Guiding Clinical Trials and Patient Treatment through Precision Medicine
2020-01-10, All about half-life: which one should I use? (tentative title)
2020-01-21, Considerations for Successful Clinical Development: Fundamentals and Best Practices for Clinical Trial Design, Biostatistics, and Data Management
2020-02-11, Development of Drug/Device Combinations
2020-02-24, MS Courses by Dr. Jack Henion: Advanced LC-MS/MS (Day1) & Interpretation of MS/MS CID Spectra (Day2)
2020-03-09, Animal Pharmacology Models for Oncology Drug Development
2020-03-16, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2020-04-10, Development of Multivalent Protein Conjugates as a Strategy to Engineer Drug Pharmacology
2020-05-12, Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
2020-05-22, No More Undruggables: Unconventional Approaches for Drug Discovery and Design - prodrugs, PROTACS, fragment-based design, directed evolution and beyond
2020-06-23, Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)
┬ęPharmaceutical & BioScience Society, International; Last Modified: 12/5/2019; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Origin Bioanalytical Laboratory Sacramento-based CRO for bioanalytical method development, validation, and consulting of LC-MS/MS analysis, specializing in ocular matrices
Adesis Inc. Adesis provides expertise in custom synthesis, process dev, R&D, and specialty mfg. to pharma, chemical, biomaterials, and catalysts companies
Pacific BioLabs Bay Area CRO with 37 years experience in Methods Development & Validation, Bioanalysis, Toxicology, Immunogenicity, Stability Studies & Microbiology
Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS & GC-MS/MS bioanalytical quantitation services of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad